Renal fibrosis: An update

Current Opinion in Nephrology and Hypertension

Volumn 10, Issue 3, 2001, Pages 315-320

  Zeisberg, Michael ^a   Strutz, Frank ^a   Müller, Gerhard A ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; OSTEOGENIC PROTEIN 1; SCATTER FACTOR;

APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CHRONIC KIDNEY FAILURE; FIBROBLAST; FIBROGENESIS; GLOMERULUS FILTRATION; HUMAN; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY TUBULE EPITHELIUM; PRIORITY JOURNAL; REVIEW;

EID: 0035022722     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200105000-00004     Document Type: Review

References (47)

1. On the pathogenesis of chronic renal failure in primary glomerulopathies
2. Interstitial pathomechanisms underlying progressive tubulointerstitial damage
3. Growth factor ultrafiltration in experimental diabetic nephropathy contributes to interstitial fibrosis
4. Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy
5. Expression of the C-C chemokine receptor 5 in human kidney diseases
6. Distinct T cell/renal tubular epithelial cell interactions define differential chemokine production: Implications for tubulointerstitial injury in chronic glomerulonephritides
7. Expression of adhesion molecules in kidney with experimental chronic obstructive uropathy: The pathogenic role of ICAM-1 and VCAM-1
8. Reactive oxygen species stimulate p44/42 mitogen-activated protein kinase and induce p27(Kip1): Role in angiotensin II-mediated hypertrophy of proximal tubular cells
9. Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli
10. Induction of CD14 in tubular epithelial cells during kidney disease
11. Mouse proximal tubular cell-cell adhesion inhibits apoptosis by a cadherin-dependent mechanism
12. Disruption of epithelial cell matrix interactions induces apoptosis
13. Activated Ras prevents downregulation of Bcl-X(L) triggered by detachment from the extracellular matrix. A mechanism of Ras-induced resistance to anoikis in intestinal epithelial cells
14. Transdifferentiation comes of age
15. Early role of Fsp1 in epithelial-mesenchymal transformation
16. Basic fibroblast growth factor (FGF-2) expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation
17. Progressive renal fibrosis in murine polycystic kidney disease: An immunohistochemical observation
18. Biology of TGF-beta in knockout and transgenic mouse models
19. Transforming growth factor-beta1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction
20. Gene therapy by transforming growth factor-beta receptor-IgG Fc chimera suppressed extracellular matrix accumulation in experimental glomerulonephritis
21. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney
22. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/ReIA
23. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta
24. CTGF modulates cell cycle progression in cAMP-arrested NRK fibroblasts
25. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene
26. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: Down-regulation by cAMP
27. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts
28. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model
29. Transforming growth factor (TGF)-β1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2)
30. TGF-beta(1) genotype and accelerated decline in lung function of patients with cystic fibrosis
31. Host genetic factors influence disease progression in chronic hepatitis C
32. Renal failure after clinical heart transplantation is associated with the TGF-beta1 codon 10 gene polymorphism
33. Genetic control of the circulating concentration of transforming growth factor type beta1
34. Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions affer renal injury
35. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease
36. Hepatocyte growth factor in renal regeneration, renal disease and potential therapeutics
37. Reciprocal balance of hepatocyte growth factor and transforming growth factor-beta 1 in renal fibrosis in mice
38. Effects of pentoxifylline, pentifylline and gamma-interferon on proliferation, differentiation, and matrix synthesis of human renal fibroblasts
39. Interferon-gamma inhibits experimental renal fibrosis
40. Induction of nephrogenic mesenchyme by osteogenic protein 1 (bone morphogenetic protein 7)
41. Characterization of receptors for osteogenic protein-1/bone morphogenetic protein-7 (OP-1/BMP-7) in rat kidneys
42. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction
43. Congenital nephrotic syndrome in mice lacking CD2-associated protein
44. CD2AP is expressed with nephrin in developing podocytes and is found widely in mature kidney and elsewhere
45. Features of systemic lupus erythematosus in Dnase1-deficient mice
46. T-cell-dependent fibrosis in the mdx dystrophic mouse
47. Role for transforming growth factor-beta1 in Alport renal disease progression